See What HealthDay Can Do For You
Contact Us

Two Pancreatic-Enzyme Products Approved

Ultresa (pancrelipase) and Viokace (pancrelipase) approved to aid food digestion

THURSDAY, March 1 (HealthDay News) -- Two drugs that supplement the digestion-aiding actions of pancreatic enzymes have been approved by the U.S. Food and Drug Administration, the agency said Thursday in a news release.

Ultresa (pancrelipase) was approved for adults and children with cystic fibrosis and other disorders that affect food digestion because the pancreas does not produce enough enzymes, the FDA said.

The second drug, Viokace (pancrelipase), is to be used in combination with a proton pump inhibitor to treat adults with pancreatitis. This drug's safety and effectiveness have not been established in children, the agency said.

About 200,000 people in the United States have "pancreatic insufficiency" disorders, according to the FDA. The two new medications are the fourth and fifth to be approved for these conditions.

Both new drugs are produced by Aptalis Pharma US, based in Bridgewater, N.J.

More information

Medline Plus has more about pancreatic diseases.

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.